Leishmania dual-specificity tyrosine-regulated kinase 1 (DYRK1) is required for sustaining Leishmania stationary phase phenotype

Rocha, Vinícius Pinto Costa; Dacher, Mariko; Young, Simon Alan; Kolokousi, Foteini; Efstathiou, Antonia; Späth, Gerald Frank; Soares, Milena Botelho Pereira; Smirlis, Despina.
Artigo em Inglês | Arca: Repositório institucional da Fiocruz | ID: arc-43539

Documentos relacionados

  1. Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases.
  2. The Omnipresence of DYRK1A in Human Diseases.
  3. Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice.
  4. Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.
  5. Enforced dual-specificity tyrosine-regulated kinase 2 expression by adenovirus-mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer.
  6. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.
  7. DYRK2 maintains genome stability via neddylation of cullins in response to DNA damage.
  8. Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases.
  9. DYRK2 promotes chemosensitivity via p53-mediated apoptosis after DNA damage in colorectal cancer.
  10. New insights into the roles for DYRK family in mammalian development and congenital diseases.